Clinical Trial Detail

NCT ID NCT03147612
Title Study of the Combination of Low-Intensity Chemotherapy and Ponatinib in Patients With Philadelphia Chromosome (Ph)-Positive and/or BCR-ABL Positive Acute Lymphoblastic Leukemia (ALL)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors M.D. Anderson Cancer Center
Indications

acute lymphocytic leukemia

Therapies

Mesna

Vincristine

Dexamethasone

Rituximab

Filgrastim

Ponatinib

Cyclophosphamide

Methotrexate

Cytarabine

Age Groups: adult senior

Additional content available in CKB BOOST